Advisory Board and Editors Neurology
Alexandre Quintas
Dr. Alexandre Quintas is a Senior Associate Professor at Egas Moniz University, Lisbon, Portugal. He holds a PhD in Biological Chemistry.
Dr. Quintas' primary areas of research focus on tackling the
novel psychoactive substances issue, linking its use to neurodegenerative diseases.
Michael A. Rogawski
Professor, Department of Neurology, School of Medicine; Pharmacology and Toxicology Graduate Group; Center for Neuroscience; University of California, Davis. Past president, American Society for Experimental NeuroTherapeutics. Academic editor of 9 journals. Co-founder of Epilepsy Currents, the journal of the American Epilepsy Society.
I received a B.A. (biophysics) from Amherst College, and M.D. and Ph.D. (pharmacology) degrees from Yale University. I was a resident, fellow and assistant professor in the Department of Neurology at the Johns Hopkins University School of Medicine. For over 20 years, I was a senior investigator and chief of the Epilepsy Research Section at the National Institute of Neurological Disorders and Stroke. My research interests involve ion channel pharmacology and neurological therapeutics, including antiepileptic drugs and other epilepsy treatment approaches.
Alessandro M Viganò
Dr. Alessandro Viganò is a Neurologist at the Fondazione Don Gnocchi in Italy.
His areas of expertise include Headaches, Migraine, Severe Brain Injury, Strokes, Dysphagia, Focal Muscle Vibration.
Benjamin J. Whalley
Senior Lecturer in Pharmacology, University of Reading. British Neuroscience Association Local Group Representative. British Pharmacological Society (Member). UK Epilepsy Research Network (Interventions & Therapies CWG). Pharmacist (GPhC registered).
Investigating unmet clinical need in epilepsy with a specific focus on cannabinoid pharmacology using preclinical animal models and electrophysiological techniques supported by convention molecular and biochemical approaches.
Hao Wu
Hao Wu is a patent scientist in an oncology-focused biotechnology company, Exelixis, Inc. She obtained her Ph.D. in molecular biology from Rowan University (previously known as the University of Medicine and Dentistry of New Jersey (UMDNJ) – Stratford Campus). With hands-on knowledge in various aspects of biology, including molecular biology, cell biology, biochemistry, immunology, neuroscience, oncology, Hao has worked on inventions spanning a broad range of technologies, for example, biologics, antibodies, biomarkers, diagnostics, cell therapy, gene therapy, and sequencing.